The antiproliferative effect of arctiin on several types of human cancer cells, including osteosarcoma, colorectal cancer, melanoma, lung cancer, breast cancer, prostate cancer, and transformed renal cells, was reported to involve the downregulation of cyclin D1 expression [19]. Here, CCND1 is linked to breast cancer.